Drugs / GC3110A
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02121782 | May → Jun 2014 | influenza | Green Cross Corporation | Completed | No outcome recorded |
| Phase 33 trials · 1 met primary | ||||||
| Phase 3 | NCT03285997 | Sep 2017 → May 2018 | — | Green Cross Corporation | Unknown | Met primary |
| Phase 3 | NCT02917304 | Oct → Dec 2016 | influenza | Green Cross Corporation | Completed | No outcome recorded |
| Phase 3 | NCT02541253 | Sep 2015 → Jun 2016 | influenza | Green Cross Corporation | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02352584 Comparator | Oct → Dec 2014 | influenza | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GC3110A | “GC3110A (Quadrivalent Influenza Vaccine)” NCT02121782 ↗ |
| Modality | Vaccine | “GC3110A (a QIV)” NCT02121782 ↗ |
| Route | Intramuscular | “GC3110A, 0.5ml, intramuscular, a single dosing at Day 1” NCT02121782 ↗ |